Error loading player: No playable sources found

3065

Farron and Martin Brotman, MD, Lecture - Key Challenges in IBD: Strategies and Solutions from the Experts

Date
May 19, 2024

SOCIETY: AGA Management of IBD is complex and challenging. This session will have IBD experts discuss evidence-based approaches to four common and challenging scenarios in IBD: choosing among available biologic and small molecule therapies based on patient profiles, proper use of therapeutic drug monitoring, management of fistulizing Crohn's, and diagnosis and management of refractory pouch disorders.

Moderators

Speaker Image for Marla Dubinsky
Icahn School of Medicine, Mount Sinai
Speaker Image for Edward Barnes
University of North Carolina School of Medicine

Related Products

Thumbnail for CHANGES IN THERAPY ARE NOT ASSOCIATED WITH INCREASED REMISSION IN PATIENTS WITH CROHN’S DISEASE OF THE POUCH
CHANGES IN THERAPY ARE NOT ASSOCIATED WITH INCREASED REMISSION IN PATIENTS WITH CROHN’S DISEASE OF THE POUCH
BACKGROUND: Prevention of postoperative recurrence (POR) in Crohn’s disease (CD) after ileo-colonic (IC) resection is still a highly debated topic. Prophylactic immunosuppression after surgery is currently recommended in presence of at least one clinical risk factor (RF)…
Thumbnail for AGA Farron and Martin Brotman, MD, Lecture — Transforming IBD Care 1: The Biologic Revolution — Past, Present and Future
AGA Farron and Martin Brotman, MD, Lecture — Transforming IBD Care 1: The Biologic Revolution — Past, Present and Future
There are multiple new biologic agents that have been approved for the management of IBD over the past few years. In addition, high quality randomized controlled trials have examined optimization of these treatments through therapeutic drug monitoring…
Thumbnail for Epithelial Junctions and Barrier Function
Epithelial Junctions and Barrier Function
MECHANOGATED ION CHANNEL PIEZO2 TETHERS TO THE ACTOMYOSIN CYTOSKELETON IN INTESTINAL EPITHELIAL MECHANORECEPTORS